Moderna Inc. (Nasdaq: MRNA US) said it would spend as much as $500 million to build a factory in Africa that could produce half a billion messenger RNA vaccine doses a year. In a statement, the company said that the new factory would produce the drug substance for messenger RNA vaccines, including its Covid-19 vaccine and shots for other diseases. Moderna’s shares have plunged 40% from their recent peak at $497,49.